Biotech Co. Celldex Completes $90M Curagen Buy
Biotechnology company Celldex Therapeutics Inc. has completed its purchase of fellow cancer drug maker Curagen Corp. for more than $90 million, the companies have announced....To view the full article, register now.
Already a subscriber? Click here to view full article